Press Release: PRAC confirms that benefits of all combined hormonal contraceptives (CHCs) continue to outweigh risks

Author (Corporate)
Series Title
Series Details EMA/607314/2013 (11.10.13)
Publication Date 11/10/2013
Content Type

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) announced, in October 2013, that it had reviewed the risk of venous thromboembolism (VTE or blood clots in veins) with combined hormonal contraceptives (CHCs). The PRAC concluded that the benefits of CHCs in preventing unwanted pregnancies continue to outweigh their risks.
Source Link http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/10/news_detail_001916.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Press Release: EMA/607314/2013 (11.10.13): PRAC confirms that benefits of all combined hormonal contraceptives (CHCs) continue to outweigh risks http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/10/WC500151960.pdf
EMA: Press Release: EMA/709120/2013 (22.11.13): Benefits of combined hormonal contraceptives (CHCs) continue to outweigh risks – CHMP endorses PRAC recommendation http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/11/news_detail_001969.jsp&mid=WC0b01ac058004d5c1
Subject Categories
Countries / Regions